Marco Roscigno
Papers
10
Total Citations
282
H-Index
8
About
Marco Roscigno is a leading urologic oncologist whose research has fundamentally advanced the surgical management of kidney cancer, particularly through partial nephrectomy. His work centers on optimizing perioperative outcomes, minimizing functional loss, and refining surgical techniques for complex renal tumors. As a key investigator in the RECORD2 and SIB Margin Score international consortia, Roscigno has driven large, prospective multicenter studies that have reshaped clinical practice. His landmark 2019 paper (93 citations) demonstrated how resection technique directly impacts surgical margins and acute kidney injury, while his 2020 study (51 citations) provided crucial comparative data on transperitoneal versus retroperitoneal approaches. He developed a validated nomogram to predict significant renal function loss after robot-assisted partial nephrectomy, a tool now used for preoperative counseling. With over 250 total citations, Roscigno’s work has established evidence-based standards for nephron-sparing surgery, showing that even highly complex tumors (PADUA score ≥10) can be safely resected. His contributions have been instrumental in defining the “Trifecta” of optimal outcomes—negative margins, minimal complications, and preserved renal function—making him a pivotal figure in modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10